On July 14, China Life Insurance (02628.HK) fell 3.42% in regular trading to HK$26.58, with turnover of HK$254 million. The stock declined for a second straight session following the company's July 10 announcement of a major semiconductor equity fund.

China Life disclosed plans to contribute 4.999 billion yuan as a limited partner to establish the Tianjin Shenghe Xincheng Equity Investment Fund with affiliate China Life Industrial Investment Management. The fund totals 5 billion yuan with an 8-year duration, targeting semiconductor process-support companies serving chip design and computing system firms, with single-target stakes capped at 3%. This marks the company's fourth large-scale equity investment this year, pushing cumulative commitments beyond 20 billion yuan across AI, healthcare, and semiconductor sectors.

The market remains divided on the capital allocation strategy, weighing long-term alignment between insurance capital duration and semiconductor development cycles against near-term deployment risk. Within the Life and Health Insurance sector, AIA rose 0.35% and NCI gained 1.06%, while Ping An fell 1.41%, China Taiping dropped 2.38%, and Sunshine Insurance declined 2.24%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)